Literature DB >> 11675580

The glaucomas.

A L Coleman1, L Brigatti.   

Abstract

Glaucoma is the leading cause of irreversible blindness worldwide. The World Health Organization reported in 1995 that 5.1 million persons were bilaterally blind from glaucoma. Its morbidity and prevalence make it a significant public health problem. Because it is a treatable condition, it is important that medical professionals be familiar with this disease, which in most cases is not associated with signs and symptoms that may alert the patient or the physician of its presence. Glaucoma is a progressive optic neuropathy that leads to blindness if left untreated. Risk factors include elevated intraocular pressure, advanced age, African ancestry and positive family history. Several types of glaucomas have been described: acute and chronic, secondary and primary. Primary (Chronic) Open Angle Glaucoma is the most common, with a prevalence in the USA of 1.55%. Blacks are 4 to 5 times more affected than whites. Treatment of glaucoma consists of topical or systemic intraocular pressure lowering agents, laser treatment or surgery. Primary Open Angle Glaucoma is an often-unrecognized disease due to its slow course and lack of symptoms. Because the decline in vision may be slowed but not restored by treatment, it is important that this condition be diagnosed early in its course.

Entities:  

Mesh:

Year:  2001        PMID: 11675580

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  16 in total

Review 1.  Benzalkonium chloride and glaucoma.

Authors:  Carol A Rasmussen; Paul L Kaufman; Julie A Kiland
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-08       Impact factor: 2.671

2.  [Neovascular glaucoma: aetiology, pathogenesis and treatment].

Authors:  K U Löffler
Journal:  Ophthalmologe       Date:  2006-12       Impact factor: 1.059

3.  Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy.

Authors:  Jimena F Schmidt; Olga A Agapova; Ping Yang; Paul L Kaufman; M Rosario Hernandez
Journal:  Br J Ophthalmol       Date:  2007-02-14       Impact factor: 4.638

4.  Improving Access to Eye Care among Persons at High-Risk of Glaucoma in Philadelphia--Design and Methodology: The Philadelphia Glaucoma Detection and Treatment Project.

Authors:  Lisa Hark; Michael Waisbourd; Jonathan S Myers; Jeffrey Henderer; John E Crews; Jinan B Saaddine; Jeanne Molineaux; Deiana Johnson; Harjeet Sembhi; Shayla Stratford; Ayman Suleiman; Laura Pizzi; George L Spaeth; L Jay Katz
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

5.  Beta 2-adrenergic receptor polymorphism and susceptibility to primary congenital and primary open angle glaucoma.

Authors:  Kivanc Güngör; Mehtap Ozkur; Ingolf Cascorbi; Jürgen Brockmöller; Necdet Bekir; Ivar Roots; A Sükrü Aynacioglu
Journal:  Eur J Clin Pharmacol       Date:  2003-09-12       Impact factor: 2.953

6.  Incidence of visual loss in rural southwest Uganda.

Authors:  S M Mbulaiteye; B C Reeves; F Mulwanyi; J A G Whitworth; G Johnson
Journal:  Br J Ophthalmol       Date:  2003-07       Impact factor: 4.638

7.  Association of OPA1 polymorphisms with NTG and HTG: a meta-analysis.

Authors:  Yatu Guo; Xia Chen; Hongtuan Zhang; Ningdong Li; Xiong Yang; Wenbo Cheng; Kanxing Zhao
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

8.  Prevalence and determinants of glaucoma in citizens of qatar aged 40 years or older: a community-based survey.

Authors:  Fatma A Al-Mansouri; Aida Kanaan; Hamad Gamra; Rajiv Khandekar; Shakeel P Hashim; Omar Al Qahtani; Mohd Farouk Ahmed
Journal:  Middle East Afr J Ophthalmol       Date:  2011-04

9.  Deep Learning for Glaucoma Detection and Identification of Novel Diagnostic Areas in Diverse Real-World Datasets.

Authors:  Erfan Noury; Suria S Mannil; Robert T Chang; An Ran Ran; Carol Y Cheung; Suman S Thapa; Harsha L Rao; Srilakshmi Dasari; Mohammed Riyazuddin; Dolly Chang; Sriharsha Nagaraj; Clement C Tham; Reza Zadeh
Journal:  Transl Vis Sci Technol       Date:  2022-05-02       Impact factor: 3.048

10.  Results of combined cyclectomy/trabeculectomy procedure compared with ahmed glaucoma valve implant in neovascular glaucoma cases.

Authors:  Kaya N Engin; Cemil Yılmazlı; Günay Engin; Levent Bilgiç
Journal:  ISRN Ophthalmol       Date:  2011-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.